Vivani Medical Inc (VANI) - News Archive

Innovative Leap in Obesity Treatment: Vivani Medical Initiates First-in-Human Trial of GLP-1 Implant in Australia In a transformative stride forward in the battle against obesity, Vivani Medical, Inc. (Nasdaq: VANI), a...

Vivani Medical Advances Innovative Drug Implants Amidst Strong Financial Backing Alameda, Calif. - In a compelling combination of scientific progress and strategic financial maneuvers, Vivani Medical, Inc. (Nasdaq: VANI...

Vivani Medical Sets Sights on Breakthrough Miniature Obesity Implant ProgramALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company specializing in long-term drug implants, recently...

Vivani Medical, a pioneering biopharmaceutical company based in Alameda, California, has announced a significant breakthrough in the field of long-term drug implants. The U.S. Food and Drug Administration (FDA) has clea...

Pioneering the Future of Veterinary Medicine: Vivani Medical Announces Landmark Progress in Combatting Feline Obesity with Innovative OKV-119 Implant In a remarkable stride towards revolutionizing the realm of veterinar...

Vivani Medical Reports First Quarter 2024 Financial Results and Provides Business UpdateALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a leading biopharmaceutical company specializing in the development of minia...